The Current Ratio of SK Biopharmaceuticals Co Ltd (326030.KS) is 1.64.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 1.64 |
| 2023-12-31 | 2.02 |
| 2022-12-31 | 2.99 |
| 2021-12-31 | 3.18 |
| 2020-12-31 | 6.16 |
| 2019-12-31 | 0.68 |
| 2018-12-31 | 2.63 |
| 2017-12-31 | 1.74 |